Zoar Ltd has completed its merger with Impact Biomedical Inc., allowing it to trade on the NYSE American under the ticker ZOAR.
| Name | Zoar Ltd |
|---|---|
| CIK | 0002078148 |
| Tickers | ZOAR |
| Exchanges | — |
| Entity type | other |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 0331 |
| State of incorporation | E9 Cayman Islands |
| Phone | 345-749-8307 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Zoar Ltd has completed its merger with Impact Biomedical Inc., allowing it to trade on the NYSE American under the ticker ZOAR.
Impact BioMedical Inc. reveals progress in its merger with Zoar Ltd, marking a significant step for both companies in the pharmaceutical preparations industry.
Zoar Ltd has received a notice of effectiveness from the SEC, indicating progress in its regulatory process within the pharmaceutical preparations industry.
Zoar Ltd files registration for a business combination with Impact BioMedical, signaling a significant shift in the pharmaceutical preparations industry.
Zoar Ltd has filed an amended registration statement, reflecting its strategic focus on business combinations in the pharmaceutical preparations sector.
16 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 6-K | 6-K | 0001493152-26-053003 | 001-43544 | 261568118 | 34 | 44400 | |||
| 2026-11-17 | CERT | NYSE AMERICAN CERTIFICATION | 0001143313-26-000057 | 001-43544 | 261564932 | 34 | 147455 | |||
| 2026-11-17 | 8-A12B | 8-A12B | 0001493152-26-052749 | 001-43544 | 261564746 | 34 | 27082 | |||
| 2026-11-03 | 425 | 425 | 0001493152-26-049726 | 333-298856 | 261514630 | 34 | 59702 | |||
| 2026-10-26 | 424B3 | 424B3 | 0001493152-26-048567 | 333-298856 | 261486548 | 33 | 10324140 | |||
| 2026-10-23 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003333 | 333-298856 | 261483357 | 33 | 1999 | ||
| 2026-10-22 | F-4/A | F-4/A | 0001493152-26-047960 | 333-298856 | 261477051 | 33 | 47180027 | 1 | 1 | |
| 2026-10-05 | F-4/A | F-4/A | 0001493152-26-045654 | 333-298856 | 261438614 | 33 | 21128410 | 1 | 1 | |
| 2026-09-17 | 425 | 425 | 0001493152-26-042978 | 333-298856 | 261384749 | 34 | 55379 | |||
| 2026-09-15 | 425 | 425 | 0001493152-26-042644 | 333-298856 | 261379006 | 34 | 68009 | |||
| 2026-09-15 | 425 | 425 | 0001493152-26-042640 | 333-298856 | 261378927 | 34 | 68964 | |||
| 2026-09-10 | F-4 | F-4 | 0001493152-26-042161 | 333-298856 | 261371220 | 33 | 112755220 | 1 | 1 | |
| 2026-08-18 | DRS/A | filename1.htm | 0001493152-26-038849 | 377-08465 | 261288263 | 33 | 35940838 | |||
| 2026-06-26 | DRS/A | filename1.htm | 0001493152-26-030355 | 377-08465 | 261130672 | 33 | 10063063 | |||
| 2026-03-02 | DRS/A | filename1.htm | 0001493152-26-008409 | 377-08465 | 26703102 | 33 | 10060975 | |||
| 2025-09-16 | DRS | filename1.htm | 0001493152-25-013600 | 377-08465 | 251315627 | 33 | 9385927 |
One latest value per concept from companyfacts (31 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ffd | NetFeeAmt | NetFeeAmt | USD | 65,114.85 | 2026-09-10 | F-4 | 2026-09-10 | 0001493152-26-042161 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 65,114.85 | 2026-09-10 | F-4 | 2026-09-10 | 0001493152-26-042161 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 471.51M | 2026-09-10 | F-4 | 2026-09-10 | 0001493152-26-042161 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-10 | F-4 | 2026-09-10 | 0001493152-26-042161 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-09-10 | F-4 | 2026-09-10 | 0001493152-26-042161 | |||
| us-gaap | Assets | Assets | USD | 23,820 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | Cash | Cash | USD | 23,820 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 23,820 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 23,820 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 1 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 1 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 0 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -88,276 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -88,276 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 88,276 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | Liabilities | Liabilities | USD | 112,096 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 23,820 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 112,096 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -88,276 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -88,276 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | OperatingExpenses | Operating Expenses | USD | 88,276 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -88,276 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | OtherLiabilities | Other Liabilities | USD | 112,000 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 112,096 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 112,096 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -88,276 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -88,276 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | |||
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 1 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 | ||
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 1 | 2025-06-06 | 2026-03-31 | F-4/A | 2026-10-22 | 0001493152-26-047960 |